Reassessing the Immune System Contribution in Multiple Sclerosis: Therapeutic Target, Biomarkers of Disease and Immune Pathogenesis

Original Research

16 August 2022

Deconvolution of B cell receptor repertoire in multiple sclerosis patients revealed a delay in tBreg maturation

Yakov A. Lomakin

, 17 more and

Alexander G. Gabibov

4,018 views

9 citations

Original Research

21 March 2022

Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology

José I. Fernández-Velasco

, 29 more and

Luisa M. Villar

3,412 views

2 citations

Original Research

28 February 2022

Long-Term Effects of Alemtuzumab on CD4+ Lymphocytes in Multiple Sclerosis Patients: A 72-Month Follow-Up

Simona Rolla

, 11 more and

Marinella Clerico

2,913 views

9 citations

Original Research

24 February 2022

Intermediate-Intensity Autologous Hematopoietic Stem Cell Transplantation Reduces Serum Neurofilament Light Chains and Brain Atrophy in Aggressive Multiple Sclerosis

Alice Mariottini

, 13 more and

Anna Maria Repice

2,746 views

12 citations

Brief Research Report

07 February 2022

Cytotoxic B Cells in Relapsing-Remitting Multiple Sclerosis Patients

Vinícius O. Boldrini

, 12 more and

Leonilda M. B. Santos

5,984 views

8 citations

Brief Research Report

01 February 2022

CCR6 and CXCR6 Identify the Th17 Cells With Cytotoxicity in Experimental Autoimmune Encephalomyelitis

Lifei Hou

and

Koichi Yuki

8,874 views

23 citations

Original Research

20 January 2022

Constructing a Multiple Sclerosis Diagnosis Model Based on Microarray

Haoran Li

, 4 more and

Wei Peng

2,023 views

4 citations

Original Research

13 January 2022

Tim-3 Relieves Experimental Autoimmune Encephalomyelitis by Suppressing MHC-II

Lili Tang

, 11 more and

Gencheng Han

4,246 views

15 citations

Original Research

16 December 2021

Soluble Receptor Isoform of IFN-Beta (sIFNAR2) in Multiple Sclerosis Patients and Their Association With the Clinical Response to IFN-Beta Treatment

Pablo Aliaga-Gaspar

, 13 more and

Begoña Oliver-Martos

3,454 views

7 citations

Original Research

14 December 2021

Treatment With Cladribine Selects IFNγ+IL17+ T Cells in RRMS Patients – An In Vitro Study

Minodora Dobreanu

, 5 more and

Rodica Bălaşa

3,998 views

2 citations

Original Research

08 December 2021

Long Non-Coding RNA- Associated Competing Endogenous RNA Axes in T-Cells in Multiple Sclerosis

Hani Sabaie

, 7 more and

Maryam Rezazadeh

3,250 views

10 citations

Original Research

07 December 2021

Identification and Clinical Validation of Key Extracellular Proteins as the Potential Biomarkers in Relapsing-Remitting Multiple Sclerosis

Meng Li

, 12 more and

Di Zhong

10,452 views

26 citations

Review

07 December 2021

Long Non-Coding RNAs, Novel Offenders or Guardians in Multiple Sclerosis: A Scoping Review

Abbas Jalaiei

, 7 more and

Maryam Rezazadeh

3,701 views

12 citations

Original Research

11 November 2021

Parkinson’s Disease Is Associated With Dysregulation of Circulatory Levels of lncRNAs

Kasra Honarmand Tamizkar

, 6 more and

Soudeh Ghafouri-Fard

2,689 views

19 citations

Hypothesis and Theory

01 November 2021

Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis

Ute-Christiane Meier

, 3 more and

Jaap Michiel Middeldorp

12,694 views

48 citations

Original Research

26 October 2021

C-Reactive Protein Levels and Gadolinium-Enhancing Lesions Are Associated With the Degree of Depressive Symptoms in Newly Diagnosed Multiple Sclerosis

Yavor Yalachkov

, 7 more and

Christian Foerch

9,542 views

4 citations

Brief Research Report

21 October 2021

Growth Factors and Their Roles in Multiple Sclerosis Risk

Hui Lu

, 3 more and

Meichen Sun

4,119 views

8 citations

Original Research

08 October 2021

Role of B Cell Profile for Predicting Secondary Autoimmunity in Patients Treated With Alemtuzumab

Paulette Esperanza Walo-Delgado

, 18 more and

Luisa Maria Villar

3,599 views

6 citations

Original Research

07 October 2021

Evaluation of Natalizumab Pharmacokinetics and Pharmacodynamics: Toward Individualized Doses

Jose M. Serra López-Matencio

, 8 more and

Cecilia Muñoz-Calleja

3,552 views

18 citations